Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030 - Rootsanalysis
Roots Analysis is pleased to announce the publication of its recent study, titled, "Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030."
By: Roots Analysis
§ An analysis of the various expansion initiatives undertaken by service providers, in order to augment their respective cell therapy manufacturing capabilities, over the period 2015-2019.
§ An analysis of the recent partnerships focused on the manufacturing of cell-based therapies, which have been established in the period 2014-2019.
§ Informed estimates of the annual commercial and clinical demand for cell therapies, in terms of number of cells produced and area dedicated to manufacturing.
§ An estimate of the overall, installed capacity for manufacturing cell-based therapies based on information reported by industry stakeholders in the public domain A competitiveness analysis of biological targets, featuring insightful pictorial summaries and representations.
§ A detailed analysis of the various factors that are likely to influence the pricing of cell-based therapies, featuring different models / approaches that may be adopted by manufacturers while deciding the prices of their proprietary offerings.
§ A qualitative analysis, highlighting the various factors that need to be taken into consideration by cell therapy developers while deciding whether to manufacture their respective products in-house or engage the services of a CMO.
§ An elaborate discussion on the role of automation technologies in improving current manufacturing methods.
§ A discussion on cell therapy manufacturing regulations across various geographies, including North America, Europe, and Asia Pacific.
§ Elaborate profiles of key players (industry and non-industry)
§ A discussion on affiliated trends, key drivers and challenges, which are likely to impact the industry's evolution, under a comprehensive SWOT framework.
§ A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
§ Type of therapy
§ T-cell therapies (CAR-T therapies, TCR therapies, TIL therapies)
§ Dendritic cell therapies
§ Tumor cell therapies
§ NK cell therapies
§ Stem cell therapies
§ Source of cells
§ Scale of operation
§ Purpose of manufacturing
§ Contract manufacturing
§ In-house manufacturing
§ Key geographical regions
§ North America
§ Asia Pacific
§ Rest of the world
For additional details, please visit
+1 (415) 800 3415